XML 21 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Cumulative effect of adoption of ASU 2020-06
Common Stock
Common Stock
Warrant Issued For Vessel Consideration
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative effect of adoption of ASU 2020-06
Accumulated Deficit
Accumulated Deficit
Cumulative effect of adoption of ASU 2020-06
Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2021     12,917,027            
Beginning balance at Dec. 31, 2021 $ 671,266 $ (12,050) $ 129   $ 982,746 $ (20,726) $ (313,495) $ 8,676 $ 1,886
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 53,073           53,073    
Dividends (27,112)           (27,112)    
Issuance of shares due to vesting of equity awards (in shares)     60,890            
Issuance of shares due to vesting of equity awards 0   $ 1   (1)        
Issuance of shares upon exercise of stock options (in shares)     8,077            
Issuance of shares upon exercise of stock options 85       85        
Effect of cash flow hedges 8,681               8,681
Fees for equity offerings 201       201        
Cash used to settle net share equity awards (1,862)       (1,862)        
Stock-based compensation 1,487       1,487        
Ending balance (in shares) at Mar. 31, 2022     12,985,994            
Ending balance at Mar. 31, 2022 693,769   $ 130   961,930   (278,858)   10,567
Beginning balance (in shares) at Dec. 31, 2021     12,917,027            
Beginning balance at Dec. 31, 2021 671,266 $ (12,050) $ 129   982,746 $ (20,726) (313,495) $ 8,676 1,886
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 147,527                
Effect of cash flow hedges 10,851                
Ending balance (in shares) at Jun. 30, 2022     12,989,181            
Ending balance at Jun. 30, 2022 765,495   $ 130   963,482   (210,854)   12,737
Beginning balance (in shares) at Mar. 31, 2022     12,985,994            
Beginning balance at Mar. 31, 2022 693,769   $ 130   961,930   (278,858)   10,567
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 94,453           94,453    
Dividends (26,449)           (26,449)    
Issuance of shares due to vesting of equity awards (in shares)       3,187          
Issuance of shares upon exercise of stock options 2,170               2,170
Effect of cash flow hedges 2,170                
Cash used to settle net share equity awards (53)       (53)        
Stock-based compensation 1,605       1,605        
Ending balance (in shares) at Jun. 30, 2022     12,989,181            
Ending balance at Jun. 30, 2022 765,495   $ 130   963,482   (210,854)   12,737
Beginning balance (in shares) at Dec. 31, 2022     13,003,702            
Beginning balance at Dec. 31, 2022 819,181   $ 130   966,058   (163,556)   16,549
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 3,202           3,202    
Dividends (8,019)           (8,019)    
Issuance of shares due to vesting of equity awards (in shares)     61,358            
Issuance of shares due to vesting of equity awards 0   $ 1   (1)        
Effect of cash flow hedges (2,859)               (2,859)
Cash used to settle net share equity awards (1,651)       (1,651)        
Stock-based compensation 1,855       1,855        
Ending balance (in shares) at Mar. 31, 2023     13,065,060            
Ending balance at Mar. 31, 2023 811,709   $ 131   966,261   (168,373)   13,690
Beginning balance (in shares) at Dec. 31, 2022     13,003,702            
Beginning balance at Dec. 31, 2022 819,181   $ 130   966,058   (163,556)   16,549
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 21,228                
Effect of cash flow hedges (1,824)                
Ending balance (in shares) at Jun. 30, 2023     9,310,443            
Ending balance at Jun. 30, 2023 608,757   $ 93   745,636   (151,697)   14,725
Beginning balance (in shares) at Mar. 31, 2023     13,065,060            
Beginning balance at Mar. 31, 2023 811,709   $ 131   966,261   (168,373)   13,690
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 18,026           18,026    
Dividends (1,350)           (1,350)    
Issuance of shares due to vesting of equity awards (in shares)     26,944            
Repurchase of common stock - related party (Note 6) (in shares)     (3,781,561)            
Repurchase of common stock – related party (Note 6) (222,818)   $ (38)   (222,780)        
Effect of cash flow hedges 1,035               1,035
Stock-based compensation 2,155       2,155        
Ending balance (in shares) at Jun. 30, 2023     9,310,443            
Ending balance at Jun. 30, 2023 $ 608,757   $ 93   $ 745,636   $ (151,697)   $ 14,725